# Inventiva S.A.: financial statements, quarterly

IVA · Nasdaq · CIK 1756594 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iva.md) · [Financials](/companies/iva/financials.md) · [Filings](/companies/iva/filings.md) · [Insiders](/companies/iva/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iva/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [59.1](/filings/0001171843-21-002040.md) | [56.7](/filings/0001104659-22-032953.md) | [35.8](/filings/0001104659-23-038571.md) | [106](/filings/0001104659-24-042817.md) | [86.6](/filings/0001104659-25-035122.md) | [86.7](/filings/0001104659-25-035122.md) | [26.9](/filings/0001104659-25-035122.md) | [96.6](/filings/0001104659-25-035122.md) |
| Current assets | $m | not reported | [71.6](/filings/0001171843-21-002040.md) | [48.9](/filings/0001104659-22-032953.md) | [133](/filings/0001104659-23-038571.md) | [116](/filings/0001104659-24-042817.md) | [106](/filings/0001104659-25-035122.md) | [48.2](/filings/0001104659-25-035122.md) | [112](/filings/0001104659-25-035122.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [122](/filings/0001104659-22-032953.md) | not reported | not reported | not reported |
| Current liabilities | $m | not reported | [15.1](/filings/0001171843-21-002040.md) | [13.9](/filings/0001104659-22-032953.md) | [13.9](/filings/0001104659-23-038571.md) | [22.9](/filings/0001104659-24-042817.md) | [30.7](/filings/0001104659-25-035122.md) | [50.2](/filings/0001104659-25-035122.md) | [121](/filings/0001104659-25-035122.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [33.1](/filings/0001104659-24-042817.md) | [70.5](/filings/0001104659-25-035122.md) | [102](/filings/0001104659-25-035122.md) | [226](/filings/0001104659-25-035122.md) |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | [88.9](/filings/0001104659-22-032953.md) | not reported | not reported | not reported |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 193,236,978 at 2025-12-31, from the cover of the [20-F filed 2026-04-08](/filings/0001104659-26-040704.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.